Clinical Trials Browser

Completed × Ovarian Neoplasms × exemestane × Clear all

NCT00261027 2010-03-02

Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms